Brainstorm to announce fourth quarter and fiscal year 2022 financial results and provide a corporate update

New york , march 21, 2023 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, announced today that it will hold a conference call to update shareholders on financial results for the fourth quarter and year ended december 31, 2022, and provide a corporate update, at 8:00 a.m. eastern time on thursday, march 30th.
BCLI Ratings Summary
BCLI Quant Ranking